Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

• Auteurs principaux: Szymon Piatek (Auteur), Grzegorz Panek (Auteur), Zbigniew Lewandowski (Auteur), Mariusz Bidzinski (Auteur), Dominika Piatek (Auteur), Przemyslaw Kosinski (Auteur), Miroslaw Wielgos (Auteur)
• Format: Livre
• Publié: BMC, 2020-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background In clinical practice alterations in CA-125 concentration within normal range in patients with ovarian cancer after first-line treatment are common. Even minor increase in CA-125 concentration is associated with patients' anxiety and difficult interpretation and counselling f...